期刊文献+

Highly efficient detection of insulinotropic action of glucagon via GLP-1 receptor in mice pancreatic beta-cell with a novel perfusion microchip

Highly efficient detection of insulinotropic action of glucagon via GLP-1 receptor in mice pancreatic beta-cell with a novel perfusion microchip
原文传递
导出
摘要 Glucagon exhibits insulinotropic ability by activating cAMP through glucagon or glucagon-like peptide-1(GLP-1) receptors.To investigate the mechanism of endogenous and exogenous glucagon on insulin release,we studied the receptor selectivity on pancreatic islet beta-cells by switching the glucose concentration from 20 mmol/L to 0 mmol/L To measure the exact temporal relationship between glucagon and insulin release,we developed a quick,small volume,multi-channel polydimethylsiloxane(PDMS) microchip.At 0 mmol/L glucose,we observed an insulinotropic effect in both INS-1 cells and islets.Meanwhile,we observed a 63 ± 6.27 s delay of endogenous glucagon-induced insulin release.After treatment with glucagon and GLP-1 receptor antagonists,we found that endogenous glucagon utilized the glucagon receptor,whereas exogenous glucagon primarily utilized the GLP-1 receptor to promote insulin secretion.The microchip can also be used to describe the "glucagonocentric" vision of diabetes pathophysiology.Taken together,the insulinotropic mechanism of different receptors should be taken into account in clinical treatments. Glucagon exhibits insulinotropic ability by activating cAMP through glucagon or glucagon-like peptide-1(GLP-1) receptors.To investigate the mechanism of endogenous and exogenous glucagon on insulin release,we studied the receptor selectivity on pancreatic islet beta-cells by switching the glucose concentration from 20 mmol/L to 0 mmol/L To measure the exact temporal relationship between glucagon and insulin release,we developed a quick,small volume,multi-channel polydimethylsiloxane(PDMS) microchip.At 0 mmol/L glucose,we observed an insulinotropic effect in both INS-1 cells and islets.Meanwhile,we observed a 63 ± 6.27 s delay of endogenous glucagon-induced insulin release.After treatment with glucagon and GLP-1 receptor antagonists,we found that endogenous glucagon utilized the glucagon receptor,whereas exogenous glucagon primarily utilized the GLP-1 receptor to promote insulin secretion.The microchip can also be used to describe the "glucagonocentric" vision of diabetes pathophysiology.Taken together,the insulinotropic mechanism of different receptors should be taken into account in clinical treatments.
出处 《Chinese Chemical Letters》 SCIE CAS CSCD 2016年第7期1027-1031,共5页 中国化学快报(英文版)
基金 supported by the National Natural Science Foundation of China (Nos. 41076064, 31371444)
关键词 GLUCAGON INSULIN Glucagon receptor GLP-1 receptor MICROCHIP Glucagon Insulin Glucagon receptor GLP-1 receptor Microchip
  • 相关文献

参考文献27

  • 1E.W. Sutherland, C. De Duve, Origin and distribution of the hyperglycemic- glycogenolytic factor of the pancreas, J. Biol. Chem. 175 (1948) 663-674.
  • 2R.H. Unger, A.D. Cherrington, Glucagonocentric restructuring of diabetes: a pathophysiologic and therapeutic makeover, J. Clin. Invest. 122 (2012) 4-12.
  • 3B.E. Dunning, J.E. Gerich, The role of a-cell dysregulation in fasting and postpran- dial hyperglycemia in type 2 diabetes and therapeutic implications, Endocr. Rev. 28 (2007) 253-283.
  • 4Y. Lee, E.D. Berglund, X.X. Yu, et al., Hyperglycemia in rodent models of type 2 diabetes requires insulin-resistant alpha cells, Proc. Natl. Acad. Sci. U. S. A. 111 (2014) 13217-13222.
  • 5R.H. Unger, L. Orci, The essential role of glucagon in the pathogenesis of diabetes mellitus, Lancet 305 (1975) 14-16.
  • 6A.D. Baron, L. Schaeffer, P. Shragg, O.G. Kolterman, Role of hyperglucagonemia in maintenance of increased rates of hepatic glucose output in type II diabetics, Diabetes 36 (1987) 274-283.
  • 7H.Y. Gaisano, P.E. Macdonald, M. Vranic, Glucagon secretion and signaling in the development of diabetes, Front. Physiol. 3 (2012) 349.
  • 8S. Malmgren, B. Ahr~n, Evidence for time dependent variation of glucagon secretion in mice, Peptides 76 (2016) 102-107.
  • 9L.R. Nyman, K.S. Wells, W.S. Head, et al., Real-time, multidimensional in vivo imaging used to investigate blood flow in mouse pancreatic islets, J. Clin. Invest. 118 (2O08) 3790-3797.
  • 10E. Samols, G. Marri, V. Marks, Interrelationship of glucagon, insulin and glucose: the insulinogenic effect of glucagon, Diabetes 15 (1966) 855-866.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部